Posted by SLS on January 2, 2023, at 16:05:34
In reply to Tentative remission on ketamine, posted by beckett2 on December 29, 2022, at 20:53:47
Hi, Beckett.
"Lumateperone normalizes pathological levels of acute *inflammation* through important pathways known to be involved in mood regulation"
https://pubmed.ncbi.nlm.nih.gov/36549907/
I suggested to one person who failed to respond to lurasodone (Latuda) if they might look into lumateperone (Caplyta) for treating depression. I have not seen Latuda have a good track record for treating depression. Caplyta has an FDA indication for Bipolar I and II depression. Regarding inflammation, I found only one article describing inflammation as possibly being involved with the mechanism of action of lumaterpersone.
- Scott
Some see things as they are and ask why.
I dream of things that never were and ask why not.The only thing necessary for the triumph of evil is that good men do nothing.
poster:SLS
thread:1121402
URL: http://www.dr-bob.org/babble/20220917/msgs/1121468.html